Use of dehydroepeiandrosterone-3-carboxylates to control body weight
US5807848A · kind A · utility
6Cited by
2References
39Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 16, 1996 |
| Grant date | Sep 15, 1998 |
| Priority date | — |
| Expiry date | Dec 16, 2016 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5685
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Method of prophylactically averting weight gain, promoting weight loss and treating obesity with a family of thermogenic steroids. Such steroids include substantially pure .DELTA.5 Androstene-17-ones having an ester of a saturated, unbranched C.sub.2-24 monocarboxylic acid attached at the 3.beta.-position of the base steroid ring.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.